Suárez‐Calvet, M., Karikari, T. K., Ashton, N. J., Rodríguez, J. L., Milà‐Alomà, M., Gispert, J. D., . . . Vilor‐Tejedor, N. Novel tau biomarkers phosphorylated at T181, T217 or T231 rise in the initial stages of the preclinical Alzheimer’s continuum when only subtle changes in Aβ pathology are detected. Springer Nature.
Chicago Style (17th ed.) CitationSuárez‐Calvet, Marc, et al. Novel Tau Biomarkers Phosphorylated at T181, T217 or T231 Rise in the Initial Stages of the Preclinical Alzheimer’s Continuum When Only Subtle Changes in Aβ Pathology Are Detected. Springer Nature.
MLA (9th ed.) CitationSuárez‐Calvet, Marc, et al. Novel Tau Biomarkers Phosphorylated at T181, T217 or T231 Rise in the Initial Stages of the Preclinical Alzheimer’s Continuum When Only Subtle Changes in Aβ Pathology Are Detected. Springer Nature.